- 14 March
-
At the end of the last year, Novouralsk-based Medsintez Plant turned 20 years old. Alexander Petrov, Chairman of the plant's Board of Directors, told Regions of Russia about the impressive successes that the company has achieved over the years and its ambitious plans for the future.
- 22 January
-
In 2023, the Medsintez Plant, in collaboration with the Promomed Group of Companies, launched the production of a full cycle of hypoglycemic drugs Enligria (liraglutide) and Quincenta (semaglutide) used in treating type II diabetes mellitus, including in patients with obesity and overweight or cardiovascular disease. The preparations are available in the most convenient and familiar for patients dosage form – a disposable prefilled injection and have already been supplied to pharmacies.
- 13 December
-
Medsintez Plant LLC presented the latest biotechnological developments of pharmaceuticals at the largest international scientific and practical forum in the field of medicine and health care Russian Health Care Week — 2023 held from December 4 to December 8 in Moscow. The main purpose of the Forum is to facilitate the implementation of the national projects “Healthcare” and “Demography”, “Tourism and Hospitality Industry”, the federal project “Development of Medical Services Export”, as well as summarizing the results of the Year of Science and Technology in Medicine.
- 04 October
-
On September 27, as part of the business program of the GMP conference with international participation, Alexander Petrov, Chairman of the Board of Directors of Medsintez Plant LLC, took part in a Plenary Session on the issues of regulating the circulation of medicines in Russia and the EAEU, developing import independence, and increasing export potential. The session was attended by representatives of the Ministry of Industry and Trade of the Russian Federation, the Minister of Health of the Republic of Nicaragua, the WHO Representative in Russia, a Representative of the Serbian Ministry of Health and other Russian and foreign experts. Mr. Petrov spoke about the problems that Russian pharmaceutical companies face when entering international markets and suggested possible solutions.
- Home
- Cluster members
- UME Vektor
UME Vektor
At present, UME Vektor is a modern enterprise with a powerful production potential, a wide range of advanced technologies, a high professional level of personnel, and a well-established product quality control system.
Physiotherapy device Nov-M
Medical device Nov-M is a physiotherapy device that uses electromagnetic radiation and magnetic fields. The device is intended for use in research and medical institutions, as well as for home treatment.
The device operates in two main modes: microwave therapy and magnetic therapy.
The microwave module of the device is used for the prevention and treatment of diseases of the upper respiratory tract: bronchial asthma, bronchitis, laryngitis.
The magnetic module is used for a wide range of diseases: joints, skin, pelvic organs, nervous system, as well as surgical diseases.
The device has the following specifications:
– carrier frequency of electromagnetic radiation of the microwave therapy module (4,20 ± 0,05) ГГц;
– frequency deviation of the electromagnetic radiation generated by the device by the microwave therapy module is at least 25 MHz;
– electromagnetic energy flux density at a distance of 5 cm from the device antenna has a level of 5 to 20 μW/cm2;
– induction of magnetic fields generated by the magnetic belt of the device has a level not exceeding 15 mT;
– the device provides indication and alarm: the presence of mains power supply, a constant supply voltage of 5 V, a constant supply voltage of 15 V – by steady light of yellow indicators, switching on the operating mode of individual elements of the device – by steady light of green indicators, malfunctions of individual elements of the device – by steady light of blue indicators, the end of the procedure – by steady light of blue indicator and sound alarm 10 seconds before the end of therapy;
– the device provides information on the display: therapy mode selection (microwave or magnetic), selection of the duration of the procedure (for microwave: 2, 4, 6, 8, 10 minutes, for magnetic: 4, 8, 12, 16, 24, 28 minutes), countdown of the procedure time;
– the device provides automatic shutdown of the operating mode of the procedure after the expiration of the procedure time;
– the time for setting the operating mode of the device after switching on does not exceed 1 s.
– the weight of the device does not exceed 5 kg;
– overall dimensions of the device (without accessories) no more than 280 x 260 x 180 mm;
– the device operates from AC mains with a frequency of 50 Hz and a rated voltage of 220 V with mains voltage deviations of ± 10% of the rated value;
Warranty period – 12 months
Company Contacts:
28, Gagarina St., Ekaterinburg, 620078, Russia
Tel.: (343) 375-42-20, 374-04-33
Fax: (343) 374-15-91, 349-50-51
E-mail: vektor@vektor.ru
Web site: www.vektor.ru
